Skip to main content
Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

More about this publication?
Volume 10, Number 24, 2004

Book review

Review article

Radionuclide Imaging in Drug Development
pp. 2907-2921(15)
Authors: Perkins, Alan C.; Frier, Malcolm

Favourites:
ADD

Radiolabeled Compounds in the Development of Cytotoxic Agents
pp. 2923-2934(12)
Authors: Kairemo, Kalevi J.A.; Tahtinen, Marja

Favourites:
ADD

Radiolabeled Compounds in Diagnosis of Infectious and Inflammatory Disease
pp. 2935-2950(16)
Authors: Bleeker-Rovers, C. P.; Boerman, O. C.; M. Rennen, H. J.J.; M. Corstens, F. H.; Oyen, W. J.G.

Favourites:
ADD

Development and Clinical Application of Peptide-Based Radiopharmaceuticals
pp. 2951-2963(13)
Authors: Gotthardt, M.; Boermann, O. C.; Behr, T. M.; Behe, M. P.; Oyen, W. J.G.

Favourites:
ADD

Imaging Drug Resistance with Radiolabeled Molecules
pp. 2965-2979(15)
Authors: Vaidyanathan, G.; Zalutsky, M. R.

Favourites:
ADD

Targeted Liposomal Drug Delivery in Cancer
pp. 2981-2989(9)
Authors: Medina, Oula P.; Zhu, Ying; Kairemo, Kalevi

Favourites:
ADD

The Use of Radiolabeled Compounds for ADME Studies in Discovery and Exploratory Development
pp. 2991-3008(18)
Authors: Marathe, P. H.; Shyu, W. C.; Humphreys, W. G.

Favourites:
ADD
Favourites:
ADD

Peptide-Mediated Delivery of Therapeutic and Imaging Agents Into Mammalian Cells
pp. 3033-3044(12)
Authors: Stefanidakis, Michael; Koivunen, Erkki

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content